KOD
Kodiak Sciences Inc. · Healthcare · Biotechnology
Señales de momentum (gestores comparables):
amplitud de titulares +12.5% ·
flujo de acciones +12.1% ·
nuevas posiciones netas +11.1%
· fórmula
Acumulación amplia: acciones en aumento entre más titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q3 2025
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 78 | +7 | 23.28M | $907.00M | +13 | −5 |
| Q1 2026 | 73 | +1 | 22.77M | $867.18M | +7 | −7 |
| Q4 2025 | 73 | 0 | 22.52M | $629.54M | +1 | n/a |
| Q3 2025 | 18 | +2 | 13.89M | $227.40M | +2 | n/a |
| Q2 2025 | 13 | 0 | 11.40M | $42.51M | +1 | −1 |
| Q1 2025 | 10 | +1 | 5.74M | $16.11M | +1 | n/a |
| Q4 2024 | 9 | -1 | 5.98M | $59.47M | +2 | −3 |
| Q3 2024 | 9 | +3 | 2.45M | $6.41M | +3 | n/a |
| Q2 2024 | 6 | n/a | 2.71M | $6.38M | n/a | n/a |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (pasivo) | 2.95M | -17.5% | $48.33M | 0.0% | ▼ Trim | 2 | SEC ↗ ×8 |
| 2 | Point72 Asset Management ✦ | 2.84M | +526.7% | $46.44M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 3 | The Vanguard Group ✦ (pasivo) | 1.95M | +7.0% | $31.93M | 0.0% | ▲ Add | 2 | SEC ↗ ×3 |
| 4 | Adage Capital Partners ✦ | 1.33M | -35.1% | $21.85M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 5 | State Street Global Advisors ✦ (pasivo) | 832.44K | -0.6% | $13.63M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 6 | Geode Capital Management ✦ (pasivo) | 801.44K | +1.5% | $13.12M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 7 | Morgan Stanley ✦ | 647.59K | n/a | $10.60M | 0.0% | n/c | 1 | SEC ↗ ×9 |
| 8 | T. Rowe Price ✦ | 502.22K | +1202.4% | $8.22M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 9 | Renaissance Technologies ✦ | 461.30K | -39.6% | $7.55M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 10 | D. E. Shaw & Co. ✦ | 457.86K | -23.9% | $7.50M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 11 | Goldman Sachs Group ✦ | 326.78K | n/a | $5.35M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 12 | Fidelity (FMR) ✦ | 263.05K | +4.3% | $4.31M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 13 | Millennium Management ✦ | 155.25K | Nuevo | $2.54M | 0.0% | New | 1 | SEC ↗ |
| 14 | Two Sigma Investments ✦ | 138.26K | +158.9% | $2.26M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 15 | Wellington Management ✦ | 117.06K | +26.5% | $1.92M | 0.0% | ▲ Add | 2 | SEC ↗ ×3 |
| 16 | Citadel Advisors ✦ | 45.45K | Nuevo | $744,098 | 0.0% | New | 1 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 41.17K | -27.3% | $674,003 | 0.0% | ▼ Trim | 3 | SEC ↗ ×5 |
| 18 | JPMorgan Chase ✦ | 26.39K | n/a | $431,970 | 0.0% | n/c | 1 | SEC ↗ ×4 |
"Their weight" = la participación de la posición en el valor de renta variable 13F reportado por ese manager: la medida de convicción. ✦ = manager curado.
Nuevos compradores
| Millennium Management | $2.54M | 0.0% |
| Citadel Advisors | $744,098 | 0.0% |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 186 tenedores, 57.91M acciones, $2.09B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué más suelen tener los titulares rastreados de este valor: recuentos de titularidad compartida, no relaciones fundamentales.
Compras en mercado abierto (P)
Director, 10% owner · 1.42K acc. @ 85.89 · $121,614
Director, 10% owner · 84 acc. @ 85.89 · $7,214
Director, 10% owner · 10.38K acc. @ 84.24 · $874,517
Director, 10% owner · 1.20K acc. @ 85.40 · $102,057
Director, 10% owner · 20.03K acc. @ 85.40 · $1.71M
Director, 10% owner · 619 acc. @ 84.24 · $52,146
Director, 10% owner · 44.69K acc. @ 61.63 · $2.75M
Director, 10% owner · 2.67K acc. @ 61.63 · $164,293
Director, 10% owner · 61 acc. @ 80.52 · $4,912
Director, 10% owner · 8.02K acc. @ 64.43 · $516,774
Ventas en mercado abierto (S)
Sin ventas en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología
35.0% de clase · Ver presentación original ante la SEC ↗